OpenURL Connection Search

Select item for more details and to access through your institution.

Immunodominant antibody responses directed to SARS-CoV-2 hotspot mutation sites and risk of immune escape.
Published in:
Frontiers in Immunology, 2023, v. 13, p. 1, doi. 10.3389/fimmu.2022.1010105
By:
- Oliveira, Jamille Ramos;
- Ruiz, Cesar Manuel Remuzgo;
- Machado, Rafael Rahal Guaragna;
- Magawa, Jhosiene Yukari;
- Daher, Isabela Pazotti;
- Urbanski, Alysson Henrique;
- Schmitz, Gabriela Justamante Händel;
- Arcuri, Helen Andrade;
- Ferreira, Marcelo Alves;
- Sasahara, Greyce Luri;
- de Medeiros, Giuliana Xavier;
- Júnior, Roberto Carlos Vieira Silva;
- Durigon, Edison Luiz;
- Boscardin, Silvia Beatriz;
- Rosa, Daniela Santoro;
- Schechtman, Deborah;
- Nakaya, Helder I.;
- Cunha-Neto, Edecio;
- Gadermaier, Gabriele;
- Kalil, Jorge
Publication type:
Article
Enhanced Immunogenicity and Protective Effects against SARS-CoV-2 Following Immunization with a Recombinant RBD-IgG Chimeric Protein.
Published in:
Vaccines, 2024, v. 12, n. 4, p. 356, doi. 10.3390/vaccines12040356
By:
- Silva, Mariângela de Oliveira;
- Castro-Amarante, Maria Fernanda;
- Venceslau-Carvalho, Alexia Adrianne;
- Almeida, Bianca da Silva;
- Daher, Isabela Pazotti;
- Souza-Silva, Guilherme Antonio de;
- Yamamoto, Marcio Massao;
- Koike, Gabriela;
- de Souza, Edmarcia Elisa;
- Wrenger, Carsten;
- Ferreira, Luís Carlos de Souza;
- Boscardin, Silvia Beatriz
Publication type:
Article
Anti-RBD IgG antibodies from endemic coronaviruses do not protect against the acquisition of SARS-CoV-2 infection among exposed uninfected individuals.
Published in:
Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1396603
By:
- Lopes Adami, Flávia;
- de Castro, Mateus Vidigal;
- da Silva Almeida, Bianca;
- Pazotti Daher, Isabela;
- Massao Yamamoto, Márcio;
- Santos, Keity Souza;
- Zatz, Mayana;
- Satya Naslavsky, Michel;
- Santoro Rosa, Daniela;
- Cunha-Neto, Edecio;
- Leite de Oliveira, Vivian;
- Kalil, Jorge;
- Boscardin, Silvia Beatriz
Publication type:
Article

Found: 3

Immunodominant antibody responses directed to SARS-CoV-2 hotspot mutation sites and risk of immune escape.

Enhanced Immunogenicity and Protective Effects against SARS-CoV-2 Following Immunization with a Recombinant RBD-IgG Chimeric Protein.

Anti-RBD IgG antibodies from endemic coronaviruses do not protect against the acquisition of SARS-CoV-2 infection among exposed uninfected individuals.